prifemilast

Narrative intelligence for prifemilast: 1 tracked articles, claims, and spin patterns across AI and technology coverage.

SPIN Processed Press Release Frame: The Cushion

cAMPfield Strengthens Leadership Team with Key Executive Appointments, Including Graham Heap, MD, PhD as President, R&D, to Advance Prifemilast into Global Phase 2 Development for Inflammatory Bowel Disease

cAMPfield, a biotech company developing prifemilast for inflammatory bowel disease, announced executive leadership appointments to advance the drug into global Phase 2 clinical trials.

Spin 65% Claim Present in Source AI Risk Moderate

PR Newswire Technology

Aug 3, 2026

Related Claims

01 cAMPfield is advancing prifemilast into global Phase 2 development for inflammatory bowel disease.

Markdown (.md) · JSON-LD schema (.json) · Machine-readable for AI & GEO